Tauriga Sciences, Inc. Granted Extension Until July 6, 2016 to Respond to Motions Recently Filed by Cowan Gunteski & Co. P.A.
NEW YORK, NY, Jun 30, 2016 (Marketwired via COMTEX) — NEW YORK, NY–(Marketwired – Jun 30, 2016) – Tauriga Sciences, Inc. (otc pink:TAUG) (“Tauriga” or “the Company”), a life sciences technology company, today announced that Judge Robin L. Rosenberg granted Tauriga Sciences, Inc. an extension until July 6, 2016 to respond to the multiple motions filed by Cowan Gunteski & Co. P.A. on June 13, 2016 with regard to the Company’s currently pending action in the Federal District Court – Southern District Florida. The history of the action is more fully described in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2015 filed with the Securities and Exchange Commission on June 29, 2016.
About TAURIGA SCIENCES, INC.:
Tauriga Sciences, Inc. (otc pink:TAUG) is a life sciences company focused on generating profitable revenues through its present and future holdings. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company’s corporate website at www.tauriga.com
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
Forward Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding Tauriga, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “may,” “will,” “expect,” “anticipate,” “estimate,” “intend,” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Examples of forward-looking statements contained in this press release include, among others, statements regarding our ability to prosecute successfully the litigation against Cowan Gunteski and the prospects of a potential acquisition. Tauriga undertakes no obligation to update or revise any forward-looking statements. The quoting and trading of the company’s common stock on the OTC Market Group’s OTC Link quotation system is often thin and characterized by wide fluctuations in trading prices, due to many factors that may have little to do with the company’s operations or business prospects. As a result, there may be volatility in the market price of the shares of the company’s common stock for reasons unrelated to operating performance. Moreover, the OTC Market Group’s OTC Link quotation system is not a stock exchange, and trading of securities on it is often more sporadic than trading of securities listed on the NASDAQ Stock market or another securities exchange.